Erol AB works with sales and marketing of pharmaceuticals.
Since its inception in January 2000, Erol AB has been manufacturing a drug - Niferex®, oral treatment for iron deficiency. Niferex is manufactured in Germany since the late 1970s and was launched in Sweden in 2000. In a number of countries, Niferex is the market leader in oral iron drugs. The product is called Ferro Sanol Duodenal in the following countries: Algeria, Iran, Lebanon, Egypt, Turkey, Germany and Finland as Obsidan® and Niferex in Norway and Denmark. Since May 2006 there are also Niferex oral drops.
ADDRESS
Medeon Science Park
SE-205 12 Malmö
CONTACT
David Erlich
Phone: +46 (0)70 8540835
Website: http://www.niferex.se/